8-K: CareTrust REIT Completes $736M Stock Offering

CareTrust REIT, Inc. successfully completed a public offering of 23 million shares of common stock at $32.00 per share, raising approximately $736 million in gross proceeds.

Summary

• CareTrust REIT, Inc. (CTRE) and its operating partnership, CTR Partnership, L.P., entered into an underwriting agreement for a common stock offering.
• The company sold 20,000,000 firm shares and granted underwriters a 30-day option to purchase an additional 3,000,000 shares.
• Underwriters fully exercised their option to purchase the additional 3,000,000 shares on August 13, 2025.
• A total of 23,000,000 shares of common stock were issued and delivered on August 14, 2025.
• The initial public price for the shares was $32.00 per share.
• Underwriters purchased the shares from the company at $30.72 per share, reflecting an underwriting discount.
• The offering was made pursuant to the company's automatic shelf registration statement on Form S-3, filed February 24, 2023.
• Gross proceeds from the offering are approximately $736 million (23,000,000 shares x $32.00).
• Net proceeds to the company, before deducting offering expenses, are approximately $706.56 million (23,000,000 shares x $30.72).

Sentiment

Score: 8

Explanation: The filing reports a successful and substantial capital raise, with underwriters fully exercising their option, indicating strong market confidence and efficient execution. No negative financial or operational issues are disclosed, and the company affirms compliance with various regulations and its REIT status. The lack of specific use of proceeds is a minor informational gap, but the overall event is highly positive for the company's financial flexibility.

Positives

• Successful completion of a significant common stock offering, indicating strong market demand.
• Full exercise of the underwriters' option to purchase additional shares, suggesting robust investor interest.
• The company maintains its qualification and taxation as a Real Estate Investment Trust (REIT) under the Internal Revenue Code.
• Compliance with various regulatory requirements, including the Exchange Act, Sarbanes-Oxley Act, Foreign Corrupt Practices Act (FCPA), and Money Laundering Laws.
• Maintenance of internal control over financial reporting and disclosure controls and procedures.

Risks

• Potential for legal or regulatory actions if the company fails to comply with various laws (e.g., Environmental Laws, Health Care Laws, Sanctions), though the company states compliance.
• Risks related to the accuracy of forward-looking statements, as they are not guaranteed.
• Risks associated with the company's ability to maintain its REIT status.
• Risks related to the effectiveness of internal controls and disclosure procedures.

Future Outlook

CareTrust REIT's proposed method of operation will enable it to continue meeting the requirements for qualification and taxation as a Real Estate Investment Trust (REIT) under the Internal Revenue Code.

Management Comments

• CareTrust REIT, Inc. and CTR Partnership, L.P. confirm their agreement with the several underwriters named in Schedule I hereto.
• CareTrust REIT, Inc. has taken no action designed to, or likely to have the effect of, terminating the registration of the Shares under the Exchange Act or delisting the Shares from NYSE, nor has CareTrust received any notification that the Commission or NYSE is contemplating terminating such registration or listing.
• CareTrust REIT, Inc. is in material compliance with all applicable listing requirements of NYSE.

Industry Context

This common stock offering by CareTrust REIT, a healthcare REIT, aligns with broader industry trends where REITs leverage equity markets to fund acquisitions, development, or debt reduction, especially in sectors with stable demand like healthcare. The successful execution of this large offering suggests continued investor confidence in the healthcare real estate sector and the company's specific strategy, despite potential interest rate volatility or economic uncertainties.

Comparison to Industry Standards

• The offering size of 23 million shares and gross proceeds of $736 million is substantial for a healthcare REIT, indicating strong institutional demand.
• The full exercise of the underwriters' option suggests the offering was well-received, potentially outperforming expectations for similar-sized equity raises in the current market environment.
• The underwriting discount (difference between public price and purchase price) would need to be compared to industry averages for similar offerings to fully assess its competitiveness, but the successful completion itself is a positive indicator.

Related Party Transactions

• The Tax Matters Agreement, dated as of May 30, 2014, by and between The Ensign Group, Inc. and CareTrust is mentioned as an existing tax sharing agreement.

Stakeholder Impact

• Shareholders: Existing shareholders may experience dilution due to the issuance of new shares, but the capital raise provides financial flexibility for future growth or debt reduction, potentially enhancing long-term value.
• Company: The company gains significant capital, which can be used for strategic investments, acquisitions, or strengthening its balance sheet, supporting its growth objectives as a REIT.
• Underwriters: J.P. Morgan Securities LLC, BofA Securities, Inc., and RBC Capital Markets, LLC, along with other underwriters, earned underwriting discounts and commissions from facilitating the offering.

Next Steps

• CareTrust REIT will continue to file all required reports and proxy/information statements with the SEC under the Exchange Act.
• The company will maintain its listing on the New York Stock Exchange (NYSE).
• Directors, officers, and affiliates are subject to a 45-day lock-up period following the final prospectus supplement date.

Key Dates

Recommendation

The successful completion of a significant equity raise is a positive for CareTrust REIT, providing substantial capital for future endeavors. However, the filing is purely a factual report of the offering and does not contain new operational or financial performance data that would warrant a 'buy' or 'sell' recommendation. The dilution from the new share issuance is a factor to consider, but the capital infusion strengthens the balance sheet. Investors should 'hold' and await further operational updates or strategic announcements regarding the deployment of these funds to reassess the investment thesis.

Keywords

CareTrust REIT, CTRE, Common Stock Offering, Equity Raise, Underwriting Agreement, REIT, Real Estate Investment Trust, SEC Filing, Form 8-K, Public Offering, Capital Markets